Trial intelligence / Profile preview

DBVE-PC with or without Dexrazoxane in Advanced Stage Hodgkin's Disease

NCT00005578Phase 3Completed

Sponsor
Children's Oncology Group
Start
Mar 1997
Primary completion
Oct 2004
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of dexrazoxane in Hodgkin lymphoma (HL), sponsored by Children's Oncology Group. Started Mar 1997; status: completed.

02

Drugs

dexrazoxane
03

Conditions

Hodgkin lymphoma (HL)

Beyond the preview

Go deeper on NCT00005578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call